Found 37 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia PHASE1 This phase IB trial studies the feasibility of using a functional laborator...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab PHASE2 RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Show More Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Temsirolimus-RCC-imaging PHASE2 This study uses one trialdrug: Temsirolimus (sometimes called Torisel ® ). ...
Show More Location
University Medical Centre Nijmegen
Learn More & Join Trial
Sorafenib for Imatinib/Sunitinib-failed GIST PHASE2 With discovery of KIT (CD117) mutations and the advent of KIT tyrosine kina...
Show More Location
Samsung Medical Center
Learn More & Join Trial
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. PHASE1 The purpose of this study is to evaluate the safety, tolerability and pharm...
Show More Location
Multiple Locations
Learn More & Join Trial
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS) N/A Information on the prevalence of advanced/metastatic renal cell carcinoma a...
Show More Location
Multiple Locations
Learn More & Join Trial
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib PHASE3 This is an international, randomized, open-label, outpatient, multicenter s...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Tumor Registry of Advanced Renal Cell Carcinoma N/A The purpose of this registry is to record information of therapy reality of...
Show More Learn More & Join Trial